Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Hormonal Therapy vs Chemotherapy in Advanced Breast Cancer
NCT02995772Phase 3Completed
- Sponsor
- Dharmais Cancer Hospital
- Start
- Nov 2011
- Primary completion
- Nov 2018
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label trial of anastrozole, letrozole, exemestane and tamoxifen in breast cancer (2 arms), sponsored by Dharmais Cancer Hospital. Primary endpoint: Overall Survival at 3 years. Started Nov 2011; status: completed.
02
Drugs
anastrozoleletrozoleexemestanetamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02995772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995772.